Work

Phase I/II Trial of a COX-2 Inhibitor With Limited Field Radiation for Intermediate Prognosis Patients Who Have Locally Advanced Non–Small-Cell Lung Cancer: Radiation Therapy Oncology Group 0213

Year: 2011

Type: article

Study design: Clinical Trial

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2011.03.007

Authors: Elizabeth Gore, Kyounghwa Bae, Corey Langer, Martine Extermann, Benjamin Movsas, Paul Okunieff, Gregory Videtic, Hak Choy

Institutions: Medical College of Wisconsin, RTOG Foundation, University of Pennsylvania, University of South Florida, Moffitt Cancer Center, Henry Ford Health, Henry Ford Hospital, University of Rochester, Cleveland Clinic, The University of Texas Southwestern Medical Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1730015850, Community Clinical Oncology Program, G3977125109, Radiation Therapy Oncology Group

OpenAlex ID: W1968314925

FWCI: 3.271

Cites: 46

Cited by: 25

Related to: 10